Literature DB >> 8454418

Pathology induced by interleukin-6.

B Ryffel1, M J Mihatsch, G Woerly.   

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine that plays an important role in the immune response, hemopoiesis, and host defense. Recombinant human IL-6 (rhIL-6) was administered at high doses to mice, rats, and nonhuman primates. In all species, IL-6 had an immunostimulatory and hemopoietic (especially on megakaryocytes) effect. An acute-phase response was most pronounced in nonhuman primates, which was, however, not associated with any significant histopathological liver change. Finally, no evidence of glomerular pathology was found. Neutralizing antibodies were detected within 10 days of rhIL-6 administration in all species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454418

Source DB:  PubMed          Journal:  Int Rev Exp Pathol        ISSN: 0074-7718


  3 in total

1.  Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.

Authors:  D S Wang; S Ohdo; S Koyanagi; H Takane; H Aramaki; E Yukawa; S Higuchi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.

Authors:  M R Graf; R E Merchant
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

3.  Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). 1. General toxicity and hematological changes.

Authors:  S Klug; R Neubert; R Stahlmann; R Thiel; B Ryffel; B D Car; D Neubert
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.